
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ERRATUM article
Front. Mol. Biosci. , 14 February 2023
Sec. Molecular Diagnostics and Therapeutics
Volume 10 - 2023 | https://doi.org/10.3389/fmolb.2023.1155174
This article is an erratum on:
Endothelial-mesenchymal transition induced by metastatic 4T1 breast cancer cells in pulmonary endothelium in aged mice
An Erratum on
Endothelial-mesenchymal transition induced by metastatic 4T1 breast cancer cells in pulmonary endothelium in aged mice
by Smeda M, Jasztal A, Maleki EH, Bar A, Sternak M, Kwiatkowski G, Suraj-Prażmowska J, Proniewski B, Kieronska-Rudek A, Wojnar-Lason K, Skrzypek K, Majka M, Chrabaszcz K, Malek K and Chlopicki S (2022). Front. Mol. Biosci. 9:1050112. doi: 10.3389/fmolb.2022.1050112
Due to a production error, Supplementary Figures 1, 2, 3, 4, and 5 were not published.
The publisher apologizes for this mistake. The original version of this article has been updated.
Keywords: endothelial-mesenchymal transition, ageing, age-related endothelial dysfunction, breast cancer metastasis, Raman spectroscopy
Citation: Frontiers Production Office (2023) Erratum: Endothelial-mesenchymal transition induced by metastatic 4T1 breast cancer cells in pulmonary endothelium in aged mice. Front. Mol. Biosci. 10:1155174. doi: 10.3389/fmolb.2023.1155174
Received: 31 January 2023; Accepted: 31 January 2023;
Published: 14 February 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.